Verastem (NASDAQ:VSTM – Get Free Report) and Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) are both small-cap medical ...
Investment analysts at Leerink Partnrs issued their Q4 2025 EPS estimates for KalVista Pharmaceuticals in a report issued on Tuesday, March 25th. Leerink Partnrs analyst J. Schwartz forecasts that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback